Abstract:Study design, materials and methods : 107 women from one center with primary overactive bladder under the treatment with tolterodine extended release tablets ( 5 mg once daily) were randomly divided to an experiment (E) group (interfered with pelvic floor muscle training, PFMT, three sessions per day, 15-20 times /session, n=54 ), and a control (C) group (interfered with general health education, n=53). The total intervention were 3 months. Followed up after 6 months. Treatment efficacy was measured by micturition diary, Oxford pelvic floor muscle force scores, OABSS scores and patients' subjective KHQ quality of life scores respectively at baseline , 2 weeks ,1 month and 3 months.

Disease Correlation and Effects of Pelvic Floor Muscle Training on Tolterodine Based Treatment for Female Primary Overactive Bladder Syndrome